Immunai CTO and Co-Founder Luis Voloch on Using Deep Learning to Develop New Drugs - Ep. 176
Luis Voloch, CTO and Co-Founder of Immunai, is interviewed on the AI Podcast. He discusses using AI to map the human immune system and accelerate the development of new immunotherapies.